Slamenová Darina, Horváthová Eva, Robichová Sona, Hrusovská L'ubica, Gábelová Alena, Kleibl Karol, Jakubíková Jana, Sedlák Ján
Cancer Research Institute, Slovak Academy of Sciences, 833 91 Bratislava, Vlárska 7, Slovak Republic.
Environ Mol Mutagen. 2003;41(1):28-36. doi: 10.1002/em.10127.
The antioxidant butylated hydroxyanisole (BHA) is a rodent carcinogen that also reduces the mutagenicity and carcinogenicity of other agents. In this study, we have evaluated possible mechanisms for the antimutagenicity of BHA by investigating its effects on N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-treated Chinese hamster V79 cells. Mutant frequency was determined using the hprt/V79 assay, while plating efficiency was used to measure cytotoxicity, and apoptosis was measured by flow immunofluorocytometry. In addition, DNA strand breaks and the kinetics of strand-break rejoining were investigated by the alkaline elution of DNA and by single-cell gel electrophoresis (SCGE). Although the higher concentration of BHA (0.5 mM) increased the cytotoxicity of MNNG and the lower concentration of BHA (0.25 mM) did not change it, both concentrations were antimutagenic in MNNG-treated cells, with the greater effect occurring at the lower BHA concentration. Neither BHA nor MNNG nor BHA + MNNG increased the level of apoptotic nuclei, and BHA did not change the level of MNNG-induced DNA strand breaks, though it did inhibit their rejoining. Determination of O(6)-methylguanine-DNA-methyltransferase (MGMT) activity confirmed that V79 cells do not synthesize active MGMT protein; MGMT activity was also undetectable after MNNG and BHA + MNNG treatment. The ability of BHA to reduce the level of MNNG-induced mutations did not correlate with cytotoxicity, induction of apoptosis, the level of DNA strand break induction, or MGMT activity. A modified SCGE assay showed that BHA significantly reduced the level of formamidopyrimidine-DNA-glycosylase + endonucleaseIII-sensitive sites, which at least partially are caused by oxidative DNA lesions. The results suggest that the protective effect of BHA on MNNG-induced mutagenicity is best explained by the antioxidative activity of BHA, which may scavenge free radicals that participate in MNNG-induced mutagenicity.
抗氧化剂丁基羟基茴香醚(BHA)是一种啮齿动物致癌物,但它也能降低其他物质的致突变性和致癌性。在本研究中,我们通过研究BHA对经N-甲基-N'-硝基-N-亚硝基胍(MNNG)处理的中国仓鼠V79细胞的影响,评估了BHA抗突变性的可能机制。使用hprt/V79检测法测定突变频率,用平板效率来测量细胞毒性,通过流式免疫荧光细胞术检测细胞凋亡。此外,通过DNA的碱性洗脱和单细胞凝胶电泳(SCGE)研究DNA链断裂及链断裂重新连接的动力学。虽然较高浓度的BHA(0.5 mM)增加了MNNG的细胞毒性,较低浓度的BHA(0.25 mM)未改变其细胞毒性,但这两种浓度在MNNG处理的细胞中均具有抗突变性,且在较低BHA浓度时效果更明显。BHA、MNNG以及BHA + MNNG均未增加凋亡细胞核的水平,BHA也未改变MNNG诱导的DNA链断裂水平,不过它确实抑制了链断裂的重新连接。对O(6)-甲基鸟嘌呤-DNA-甲基转移酶(MGMT)活性的测定证实V79细胞不合成活性MGMT蛋白;在MNNG和BHA + MNNG处理后也未检测到MGMT活性。BHA降低MNNG诱导的突变水平的能力与细胞毒性、凋亡诱导、DNA链断裂诱导水平或MGMT活性无关。一种改良的SCGE检测法表明,BHA显著降低了甲酰胺嘧啶-DNA-糖基化酶+核酸内切酶III敏感位点的水平,这些位点至少部分是由氧化性DNA损伤引起的。结果表明,BHA对MNNG诱导的致突变性的保护作用最好用BHA的抗氧化活性来解释,BHA可能清除参与MNNG诱导致突变性的自由基。